Clinical Trial Detail

NCT ID NCT04068194
Title Testing the Combination of New Anti-cancer Drug Nedisertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

gallbladder carcinoma

cholangiocarcinoma

Advanced Solid Tumor

Therapies

Avelumab

Avelumab + MSC2490484A

Age Groups: senior adult

No variant requirements are available.